Filing Details
- Accession Number:
- 0001219071-11-000018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-19 11:22:10
- Reporting Period:
- 2011-07-15
- Filing Date:
- 2011-07-19
- Accepted Time:
- 2011-07-19 11:22:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1066026 | Concur Technologies Inc | CNQR | Services-Prepackaged Software (7372) | 911608052 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1219071 | Rajeev Singh | 3832 92Nd Avenue Ne Bellevue WA 98004 | President & Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-07-15 | 4,197 | $1.78 | 99,992 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-07-15 | 803 | $1.78 | 100,795 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-07-15 | 5,000 | $48.70 | 95,795 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-07-15 | 4,197 | $0.00 | 4,197 | $1.78 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-07-15 | 803 | $0.00 | 803 | $1.78 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,556 | 2003-10-01 | 2012-10-01 | No | 4 | M | Direct |
| 10,753 | 2003-10-01 | 2012-10-01 | No | 4 | M | Direct |
Footnotes
- The transaction indicated was conducted under an approved 10b5-1 Plan.
- The price indicated is the weighted average sale price for the shares sold. The individual sale prices for the shares indicated range from $48.40 to $49.15.
- The option becomes exercisable for 25% of the shares granted upon the one-year anniversary of the grant date, then in thirty-six equal monthly installments thereafter.
Billionaire Hedge Funds
